Hazardous waste material is any material which on improper disposal may cause threat to the environment. These waste materials can be generated through variety of sources such as manufacturing units, pharmaceutical companies, and healthcare companies among other end-use industries globally. These wastes include infectious, corrosive, oxidizing, radioactive and explosive waste. Therefore, this kind of waste is termed as hazardous waste as it can cost a great loss to humans and animals.
Maltodextrin is a polysaccharide which is also known as white powdered starch derivative. It is a food additive that belongs to the group of complex sugar. Production of maltodextrin is carried out through partial hydrolysis of grain starch which includes wheat, corn, rice and potatoes. This method abscond the product with less than 20% of sugar therefore it is also used in sugar substitutes such as Equal and Splenda. Maltodextrin is known to have bland flavor and smooth texture.
N-Methyl-2-Pyrrolidone (NMP) is a colorless liquid which when impure appears to be yellow. It is miscible with almost all organic solvents and water. It is known by many other names such as N-Methylpyrrolidone, N-Methylpyrrolidinone which is also known as Pharmasolve and 1-Methyl-2-Pyrrolidone. N-Methyl-2-Pyrrolidone fit in the group of dipolar aprotic solvents which include dimethyl sulfoxide and dimethylformamide. It has the property of dissolve diverse metals and hence is used on a large scale in plastics and petrochemical industries. They also have applications in the pharmaceutical, agrochemical and paints & coatings industries.
The global infusion pumps market is anticipated to grow at a steady pace during 2016-2025. The major factors influencing the demand for infusion pumps include growth in incidence of chronic pain, diabetes, gastrointestinal disorders and other debilitating chronic diseases and conditions. Auxiliary drivers if this market include the phenomenal rise in geriatric population pool and gradual technological developments in infusion pumps.
Machine vision and inspection solutions are becoming integral part of the industrial automation process. Rising awareness about the benefits of machine vision and inspection is increasing the demand for machine vision and inspection solutions globally. In addition, the demand for machine vision and inspection systems is growing rapidly with continuous advancement and reducing prices.
Camphor is a flammable, waxy, transparent or white solid which has a brawny aromatic odor. The origin of camphor comes from a large evergreen tree known as camphor laurel which is found in Asia. It is also known as kapur tree which is a timber tree in the same region. Apart from its natural origin, camphor can be synthetically produced from turpentine oil. Camphor is a flammable, waxy, transparent or white solid which has a brawny aromatic odor. The origin of camphor comes from a large evergreen tree known as camphor laurel which is found in Asia. It is also known as kapur tree which is a timber tree in the same region. Apart from its natural origin, camphor can be synthetically produced from turpentine oil. Synthetic camphor is available in the form of powder, tablets and blocks.
This report on global angina pectoris treatment market studies various drugs used for treatment of angina pectoris along with pipeline analysis of upcoming potential drugs. Angina is chest pain due to transient myocardial ischaemia, which usually occurs with physical activity or emotional stress, in the United States 10.2 million are estimated to experience angina with approximately 500,000 new cases occurring each year. Thus, drug pipeline of angina pectoris treatment market comprises potential drugs which are specific and fast in therapeutic action.
This report on global 3D bioprinters market studies various technologies used for specific applications in the field of healthcare. bioprinters helps to replicate human organs and long term goal is to create a whole organ with this technology. However, this technology is in its rudimentary stage and as the system in developing stage it is slowly being accepted in the mainstream medical field.
The mycosis fungoides market is set to project sublime growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2025 to 2033. Mycosis fungoides occurs in 70% of the patients suffering with cutaneous T cell lymphoma (CTCL), affecting initially to the skin later the infection spreads to internal organs in the later stages of the disease.
Lactic acid which is produced by the fermentation of starch is widely used as flavour enhancer, preservatives and acidulant in food and beverages. Lactic acid also aids the starting material for polylactic acid (PLA), a biodegradable polymer. Growing environmental concerns and rising demand for green packaging are some of the majors driving the market growth. Moreover, volatility the prices of crude oil is another major factor contributing towards market growth.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.